Literature DB >> 15442146

[Antiphlogistic effect of pyrazols, especially of irgapyrin, in peroral and parenteral administration].

G WILHELMI.   

Abstract

Entities:  

Keywords:  AMINOPYRINE; PYRAZOLE

Mesh:

Substances:

Year:  1950        PMID: 15442146

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  9 in total

1.  [On butazolidin therapy of human hemoblastoses].

Authors:  K E HAMPEL; D ALGENSTAEDT; H GERHARTZ
Journal:  Blut       Date:  1961-12

2.  [Combined application of local anesthetics and pyrazolon derivatives in rheumatism].

Authors:  G K KRAUCHER
Journal:  Acta Neuroveg (Wien)       Date:  1952

3.  The effect of systemically and topically applied drugs on ultraviolet-induced erythema in the rat.

Authors:  E Law; A J Lewis
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

4.  New experimental model for the primary evaluation of topical contra-inflammatory agents.

Authors:  E G Weirich; J K Longauer; A H Kirkwood
Journal:  Arch Dermatol Res       Date:  1977-08-22       Impact factor: 3.017

5. 

Authors:  P Steinmann; G Wilhelmi
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1951-12

6.  Delayed manifestation of ultraviolet reaction in the guinea-pig caused by anti-inflammatory drugs.

Authors:  N Gupta; L Levy
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

7.  Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK
Journal:  Calif Med       Date:  1952-11

8.  A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis.

Authors:  I G Otterness; E H Wiseman; D J Gans
Journal:  Agents Actions       Date:  1979-06

9.  Ibuprofen, the propionics and NSAIDs: personal reflections over four decades.

Authors:  S S Adams
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.